跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe
Approved
STANDARD
HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe
Maxx Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
9621b1ea8335cf59
Company
Maxx Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
9621b1ea8335cf59
Product Name
HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe
Artg Id
334802
Artg Name
HULIO adalimumab (rch) 40 mg/0.8 mL solution for injection pre-filled syringe
Sponsor
Maxx Pharma Pty Ltd
Company Detail Path
/organization/maxx-pharma-pty-ltd
Artg Date
2021-05-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
9621b1ea8335cf59
Type
Standard
Back to TGA Approvals